RE:RE:RE:Market is speakingLooks like OQP is raising funds: https://oqp.co.kr/ir/public-disclosure/# (see 04.29.2021)
(1) Basis for calculation of the issuance price of new stocks and the offer price
The weighted arithmetic average stock price for the past one month, the weighted arithmetic average stock price for one week, and the latest date based on the day before the date of resolution of the board of directors for issuance of this new stock in accordance with Article 5-18 (2) of “Regulations on Issuance and Disclosure of Securities” A discount rate of 9.99% is applied as the lower of the weighted arithmetic average closing price and the weighted arithmetic average closing price for the last day. If the offer price by applying the discount rate is less than the face value, the face value is used as the issuance price. (However, if it is less than the original unit, it is rounded up.)
(2) New shares issued through this capital increase are protected by the Korea Securities Depository for one year.
(3) Purpose of capital increase
end. Creditors: OncoQuest Inc. (Canada)
I. Payment method: Offset payment as the 1st non-guaranteed private equity bond
All. Total payment: KRW 188,634,999,525
la. Related disclosure: Decided to increase short-term borrowings on February 25, 2021
hemp. Matters related to the payment of shares
This paid-in capital increase is based on the company’s first corporate bonds held by third-party allocating subscribers.
This is a method of investing in kind with the paid-in capital increase (court approval procedure).
(4) Others
end. The above resolution may be changed during mediation or consultation with the relevant agencies.
I. Other incidental matters related to the issuance of new shares are entrusted to the CEO.
(5) Purpose of use of funds
Purpose of use amount (KRW)
Offset payment of the 1st unguaranteed corporate bond and paid-in capital increase
188,634,999,525